EPAS1 (endothelial PAS domain-containing protein 1) is downregulated in NSCLC due to promoter methylation and sequence genetic polymorphisms [71,72], and specifically in lung adenocarcinoma [73]. Here, EPAS1 is linked to lung adenocarcinoma.